• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 36 of 37
Views of The Facebook Inc. Logo Ahead of Earnings
TechVW’s New Horror And Facebook 3Q–5 Things To Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 4, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
FinancePfizer-Allergan could be a super inversion deal
By Stephen GandelOctober 29, 2015
Inside An Apple Inc. Store As The New iPhones Are Released
FeaturesGunboat diplomacy and Apple earnings — 5 things to know today
By Tom Huddleston Jr.October 27, 2015
League Championship Series - New York Mets v Chicago Cubs - Game Four
FeaturesApple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By Tom Huddleston Jr.October 25, 2015
CVS/Caremark will no longer cover these drugs, including Viagra
HealthCVS/Caremark will no longer cover these drugs, including Viagra
By Chris MatthewsAugust 7, 2015
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
FinanceIreland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By Tom Huddleston Jr.July 7, 2015
Why America’s patent system is not killing innovation
CommentaryWhy America’s patent system is not killing innovation
By David J. KapposMay 8, 2015
FRANCE-RESTAURANTS-BUSINESS-MCDONALDS
FeaturesMcDonald’s hikes pay, and Europe targets Apple, Google — 5 things to know today
By John KellApril 2, 2015
IL: Corporations In Illinois
FinanceFat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By Jen WiecznerFebruary 6, 2015
President Obama Remarks On Budget At Department Of Homeland Security
CommentaryU.S. corporate tax reform: why Obama’s good ideas don’t add up
By Robert PozenFebruary 5, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FinancePfizer to acquire Hospira in a deal worth about $15 billion
By Fortune EditorsFebruary 5, 2015
Earns Pfizer
FeaturesIn speed mode, FDA approves Pfizer’s big new drug early
By Jen WiecznerFebruary 4, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceZoetis shares spike on reported Ackman stake purchase
By Tom Huddleston Jr.November 11, 2014
Facebook earnings and MSG split — 5 things to know today
FeaturesFacebook earnings and MSG split — 5 things to know today
By Ben GeierOctober 28, 2014
New Targets and new houses (oh, and Ebola) — 5 things to know today
FeaturesNew Targets and new houses (oh, and Ebola) — 5 things to know today
By Ben GeierOctober 24, 2014
1...
  • 33
  • 34
  • 35
  • 36
  • 37
37
Most Popular
Economy
The U.S. had a national debt ‘home run’ in its grasp, says Jamie Dimon. But the government did nothing, and now its best option is crisis managementplaceholder alt text
By Fortune EditorsApril 8, 2026
Success
MacKenzie Scott's latest donation takes her HBCU giving to well over $1 billionplaceholder alt text
By Fortune EditorsApril 7, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.